Asian women who do not smoke in Northern California face rising lung cancer rates which are often diagnosed late due to ...

The U.S. Food and Drug Administration (FDA) has approved niraparib (Zejula) plus Akeega (abiraterone acetate) and prednisone ...

Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, ...

The YES intervention improved general and cancer-specific quality of life in AYA breast cancer survivors over six months.

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

U.S. Food and Drug Administration (FDA) Grants Priority Review to Bristol Myers Squibb's Application for Opdivo® (nivolumab) Plus Chemotherapy Combination for Classical Hodgkin Lymphoma, by Bristol ...

Rising healthcare costs and changing coverage increase financial burdens for individuals with hereditary conditions like ...

For 15 years, Suleika Jaouad has reported from the front lines of cancer treatment. Jaouad, the Emmy-winning journalist and author of “Between Two Kingdoms” and “The Book of Alchemy,” received her ...

High-dose radiation with Keytruda led to increased infiltration of various immune cells and formation of tertiary lymphoid ...

Verzenio monotherapy provided clinical benefits to 33% of patients with HR-positive, HER2-negative breast cancer after prior ...

Tukysa added to Herceptin and Perjeta improved progression-free survival versus placebo in HER2-positive metastatic breast ...

During the 2025 American Society of Hematology annual meeting, held earlier this month in Orlando, Florida, CURE sat down ...